Get startedLog in
    Picture of TuHURA Biosciences logo

    HURA — TuHURA Biosciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    TuHURA Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

    Picture of TuHURA Biosciences logoTuHURA Biosciences
    16/05/2025 02:09
    TuHURA Biosciences Inc HURA.OQ reported a quarterly adjusted loss of 15 cents​​ per share for the quarter ended March 31.  The lone analyst forecast for the quarter was for a loss of 10 cents per share.

Reported revenue was zero​; analysts expected zero.

TuHURA Biosciences Inc's reported EPS for the quarter was a loss of 15 cents​.

The company reported a quarterly loss of $6.66 million.

TuHURA Biosciences Inc shares had risen by 20.4% this quarter and lost 4.9% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts was unchanged in the last three months.​

In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for TuHURA Biosciences Inc is $15.00

This summary was machine generated from LSEG data May 16 at 01:09 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)


    QUARTER ENDINGESTIMATEACTUALBEAT, MET, MISSED
    Mar. 31 2025-0.10-0.15Missed

    Recent news on TuHURA Biosciences

    See all news